Head-to-Head

Abbott Laboratories vs. Bicara Therapeutics Inc. Common Stock

ABT

Abbott Laboratories

$102.64 -0.45%

VS BCAX

Bicara Therapeutics Inc. Common Stock

$9.76 -44.16%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTBCAX
Market Cap $178.40 billion $1.16 billion

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTBCAX
Dividend Yield 2.46% —

ABT and BCAX split the dividend factors evenly.

Risk & Sentiment

ABTBCAX
Short Interest 0.57% 1.00%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, BCAX overview, BCAX financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.